Wi Jin Kim, Hasitha Milan Samarage, David Zarrin, Keshav Goel, Christopher Chan, Xin Qi, Anthony Wang, Kalyanam Shivkumar, Jeffrey Ardell, Geoffrey P Colby
Introduction: Sympathetic activity from the superior cervical ganglion (SCG) has been shown to cause cerebral hypoperfusion in swine, similar to that seen with clinical cerebral vasospasm. Although the mechanism of such perfusion deficit has been speculated to be from pathologic cerebral vasoconstriction, the extent of sympathetic contribution to vasoconstriction has not been wellestablished.
Objective: We aimed to demonstrate that SCG stimulation in swine leads to significant cerebral vasoconstriction on digital subtraction angiography (DSA). Additionally, we aimed to show that inhibition of SCG can mitigate the effects of sympathetic-mediated cerebral vasoconstriction.
Methods: Five SCGs were surgically identified in Yorkshire swine and were electrically stimulated to achieve sympathetic activation. DSA was performed to measure and compare changes in cerebral vessel diameter. Syngo iFlow was also used to quantify changes in contrast flow through the cerebral and neck vessels.
Results: SCG stimulation resulted in 35-45% narrowing of the ipsilateral ascending pharyngeal, anterior middle cerebral and anterior cerebral arteries. SCG stimulation also decreased contrast flow through ipsilateral ascending pharyngeal, internal carotid and anterior cerebral arteries as seen on iFLow. These effects were prevented with prior SCG blockade. Minimal vessel caliber changes were seen in the posterior cerebral, posterior middle cerebral and internal carotid arteries with SCG stimulation.
Conclusion: SCG stimulation results in significant luminal narrowing and reduction in flow through various intracranial arteries in swine. The results of sympathetic hyperactivity from the SCG closely models cerebral vasoconstriction seen in human cerebral vasospasm. SCG inhibition is a potential promising therapeutic approach to treating cerebral vasospasm.
{"title":"Superior cervical ganglion stimulation results in potent cerebral vasoconstriction in swine.","authors":"Wi Jin Kim, Hasitha Milan Samarage, David Zarrin, Keshav Goel, Christopher Chan, Xin Qi, Anthony Wang, Kalyanam Shivkumar, Jeffrey Ardell, Geoffrey P Colby","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Sympathetic activity from the superior cervical ganglion (SCG) has been shown to cause cerebral hypoperfusion in swine, similar to that seen with clinical cerebral vasospasm. Although the mechanism of such perfusion deficit has been speculated to be from pathologic cerebral vasoconstriction, the extent of sympathetic contribution to vasoconstriction has not been wellestablished.</p><p><strong>Objective: </strong>We aimed to demonstrate that SCG stimulation in swine leads to significant cerebral vasoconstriction on digital subtraction angiography (DSA). Additionally, we aimed to show that inhibition of SCG can mitigate the effects of sympathetic-mediated cerebral vasoconstriction.</p><p><strong>Methods: </strong>Five SCGs were surgically identified in Yorkshire swine and were electrically stimulated to achieve sympathetic activation. DSA was performed to measure and compare changes in cerebral vessel diameter. Syngo iFlow was also used to quantify changes in contrast flow through the cerebral and neck vessels.</p><p><strong>Results: </strong>SCG stimulation resulted in 35-45% narrowing of the ipsilateral ascending pharyngeal, anterior middle cerebral and anterior cerebral arteries. SCG stimulation also decreased contrast flow through ipsilateral ascending pharyngeal, internal carotid and anterior cerebral arteries as seen on iFLow. These effects were prevented with prior SCG blockade. Minimal vessel caliber changes were seen in the posterior cerebral, posterior middle cerebral and internal carotid arteries with SCG stimulation.</p><p><strong>Conclusion: </strong>SCG stimulation results in significant luminal narrowing and reduction in flow through various intracranial arteries in swine. The results of sympathetic hyperactivity from the SCG closely models cerebral vasoconstriction seen in human cerebral vasospasm. SCG inhibition is a potential promising therapeutic approach to treating cerebral vasospasm.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"13 1","pages":"35-41"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703949/pdf/nihms-1843354.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40503859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Spozhmy Panezai, Sanket Meghpara, Ashish Kulhari, Jaskiran Brar, Laura Suhan, Amrinder Singh, Siddhart Mehta, Haralabous Zacharatos, Sara Strauss, Jawad Kirmani
Background/objective: Various strategies have been implemented to reduce acute stroke treatment times. Recent studies have shown a significant benefit of acute endovascular therapy. The JFK Comprehensive Stroke Center instituted Code Neurointervention (NI) on May 1, 2014 for the purpose of rapidly assembling the NI team and rapidly providing acute endovascular therapy.
Design/methods: We performed a retrospective analysis of all patients who had Code NI (Code NI group) called from May 1, 2014 to July 30, 2018 and compared them to patients who underwent acute endovascular treatment prior to initiation of the code (pre-Code NI group) between January 2012 and April 30, 2014. The following parameters were compared: door to puncture (DTP) and door to recanalization (DTR) times, as well as preprocedure NIHSS, 24-hour postprocedure NIHSS, and 90-day modified Rankin scores.
Results: There were 67 pre-Code NI patients compared to 193 Code NI patients. Mean and median DTP times for pre-code NI vs Code NI patients were 161 minutes(mins) vs 115mins (p<0.0001, 31.76-58.86) and 153mins vs 112mins (p <0.0001), respectively. Mean and median DTR times were 220 mins vs 167mins (p <0.0001, 37.76-69.97) and 225mins vs 171mins (p <0.0001). Mean pre-procedure NIHSS was 16 for both groups while 24 hours post procedure NIHSS was 10.6 vs 10.8 (p =.078, 1.8-2.38). Mean 90 day mRS was 2.15 vs 1.65 (p=0.036, 0.32-0.96).
Conclusion: Institution of Code NI significantly improved DTP and DTR times as well as mRS at 3-months postprocedure. Rapid assembly of the NI team, rapid availability of imaging and angiography suite, and streamlining of processes, likely contribute to these differences. These lessons and more widespread institution of such codes will further aid in improving acute stroke care for patients.
背景/目的:为了减少急性脑卒中的治疗时间,已经实施了各种策略。最近的研究表明急性血管内治疗有显著的益处。JFK综合中风中心于2014年5月1日建立了代码神经干预(NI),目的是快速组建NI团队并快速提供急性血管内治疗。设计/方法:我们对2014年5月1日至2018年7月30日期间所有接受NI代码(NI代码组)的患者进行了回顾性分析,并将其与2012年1月至2014年4月30日期间在开始代码之前接受急性血管内治疗的患者(NI代码前组)进行了比较。比较以下参数:门至穿刺(DTP)和门至再通(DTR)次数,以及术前NIHSS、术后24小时NIHSS和90天修正Rankin评分。结果:编码NI前患者67例,编码NI患者193例。NI编码前患者与NI编码后患者的平均和中位DTP时间分别为161分钟(min)和115分钟(pp pp p =)。078年,1.8 - -2.38)。平均90天mRS为2.15 vs 1.65 (p=0.036, 0.32-0.96)。结论:采用NI编码可显著改善术后3个月DTP、DTR次数及mRS。NI团队的快速组装、成像和血管造影套件的快速可用性以及流程的简化可能导致这些差异。这些经验教训和更广泛地建立这些守则将进一步有助于改善急性中风患者的护理。
{"title":"Institution of Code Neurointervention and Its Impact on Reaction and Treatment Times.","authors":"Spozhmy Panezai, Sanket Meghpara, Ashish Kulhari, Jaskiran Brar, Laura Suhan, Amrinder Singh, Siddhart Mehta, Haralabous Zacharatos, Sara Strauss, Jawad Kirmani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background/objective: </strong>Various strategies have been implemented to reduce acute stroke treatment times. Recent studies have shown a significant benefit of acute endovascular therapy. The JFK Comprehensive Stroke Center instituted Code Neurointervention (NI) on May 1, 2014 for the purpose of rapidly assembling the NI team and rapidly providing acute endovascular therapy.</p><p><strong>Design/methods: </strong>We performed a retrospective analysis of all patients who had Code NI (Code NI group) called from May 1, 2014 to July 30, 2018 and compared them to patients who underwent acute endovascular treatment prior to initiation of the code (pre-Code NI group) between January 2012 and April 30, 2014. The following parameters were compared: door to puncture (DTP) and door to recanalization (DTR) times, as well as preprocedure NIHSS, 24-hour postprocedure NIHSS, and 90-day modified Rankin scores.</p><p><strong>Results: </strong>There were 67 pre-Code NI patients compared to 193 Code NI patients. Mean and median DTP times for pre-code NI vs Code NI patients were 161 minutes(mins) vs 115mins (p<0.0001, 31.76-58.86) and 153mins vs 112mins (<i>p</i> <0.0001), respectively. Mean and median DTR times were 220 mins vs 167mins (<i>p</i> <0.0001, 37.76-69.97) and 225mins vs 171mins (<i>p</i> <0.0001). Mean pre-procedure NIHSS was 16 for both groups while 24 hours post procedure NIHSS was 10.6 vs 10.8 (<i>p</i> =.078, 1.8-2.38). Mean 90 day mRS was 2.15 vs 1.65 (<i>p</i>=0.036, 0.32-0.96).</p><p><strong>Conclusion: </strong>Institution of Code NI significantly improved DTP and DTR times as well as mRS at 3-months postprocedure. Rapid assembly of the NI team, rapid availability of imaging and angiography suite, and streamlining of processes, likely contribute to these differences. These lessons and more widespread institution of such codes will further aid in improving acute stroke care for patients.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998807/pdf/jvin-11-1-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37654744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Demitre Gweh, Sheena Khan, Lisa Pelletier, Nauman Tariq, Rafael H Llinas, Justin Caplan, Elisabeth B Marsh
Objective: Flow diversion using devices such as the "pipeline" stent is now a common treatment for unruptured intracranial aneurysms. Though much is known about the efficacy of the device, less is reported regarding potential side effects. In this study, we report the frequency and characteristics of the "post-pipeline headache."
Methods: We prospectively enrolled a cohort of 222 patients who underwent pipeline stenting for the treatment of intracranial aneurysm between 2015 and 2018. A follow-up telephone survey was conducted with a mean 21.6 months postprocedure evaluating postprocedure headaches and previous headache history. A post-pipeline headache was defined as a new headache or pain distinct from their prior headache syndrome. Information was collected regarding patient demographics, headache characteristics, headache history, and whether symptoms were ongoing. Logistic regression was used to determine factors associated with post-pipeline headache and the risk of long-term headache persistence.
Results: Eighty-eight individuals were reached by phone for follow-up; 48 (55%) of whom reported a new headache postprocedure. Patients experiencing post-pipeline headache were more likely to be young (OR 0.9; 95% CI: 0.85-0.94) and have a history of prior headaches (OR 2.4, 95% CI: 1.02-5.81). Associated motor (OR 6.1; 95% CI: 1.19-31.47), cognitive (OR 7.0; 95% CI: 081-60.33), visual (OR 5.4; 95% CI: 1.05-27.89), and vestibular (OR 4.8; 95% CI: 1.14-20.23) symptoms were associated with ongoing headache.
Conclusions: Post-pipeline headache is common, particularly in younger individuals with prior headache history, and has distinctive features. Symptoms can remit over time; however, two-thirds experience ongoing headaches, particularly those with associated migrainous features.
{"title":"The Post-Pipeline Headache: New Headaches Following Flow Diversion for Intracranial Aneurysm.","authors":"Demitre Gweh, Sheena Khan, Lisa Pelletier, Nauman Tariq, Rafael H Llinas, Justin Caplan, Elisabeth B Marsh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Flow diversion using devices such as the \"pipeline\" stent is now a common treatment for unruptured intracranial aneurysms. Though much is known about the efficacy of the device, less is reported regarding potential side effects. In this study, we report the frequency and characteristics of the \"post-pipeline headache.\"</p><p><strong>Methods: </strong>We prospectively enrolled a cohort of 222 patients who underwent pipeline stenting for the treatment of intracranial aneurysm between 2015 and 2018. A follow-up telephone survey was conducted with a mean 21.6 months postprocedure evaluating postprocedure headaches and previous headache history. A post-pipeline headache was defined as a new headache or pain distinct from their prior headache syndrome. Information was collected regarding patient demographics, headache characteristics, headache history, and whether symptoms were ongoing. Logistic regression was used to determine factors associated with post-pipeline headache and the risk of long-term headache persistence.</p><p><strong>Results: </strong>Eighty-eight individuals were reached by phone for follow-up; 48 (55%) of whom reported a new headache postprocedure. Patients experiencing post-pipeline headache were more likely to be young (OR 0.9; 95% CI: 0.85-0.94) and have a history of prior headaches (OR 2.4, 95% CI: 1.02-5.81). Associated motor (OR 6.1; 95% CI: 1.19-31.47), cognitive (OR 7.0; 95% CI: 081-60.33), visual (OR 5.4; 95% CI: 1.05-27.89), and vestibular (OR 4.8; 95% CI: 1.14-20.23) symptoms were associated with ongoing headache.</p><p><strong>Conclusions: </strong>Post-pipeline headache is common, particularly in younger individuals with prior headache history, and has distinctive features. Symptoms can remit over time; however, two-thirds experience ongoing headaches, particularly those with associated migrainous features.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"34-39"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998808/pdf/jvin-11-1-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37655152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The natural history and epidemiological aspects of traumatic injury of major cerebral venous sinuses are not fully understood. We determined the prevalence of traumatic injury of major cerebral venous sinuses and impact on the outcome of patients with traumatic brain injury, and/or head and neck trauma.
Methods: All the patients who were admitted with traumatic brain injury or head and neck trauma were identified by ICD-9-CM codes from the National Trauma Data Bank (NTDB), using data files from 2009 to 2010. NTDB represents one of the largest trauma databases and contains data from over 900 trauma centers across the United States. Presence of thrombosis, intimal tear, or dissection (traumatic injury) of major cerebral venous sinuses was identified in these patients by using Abbreviated Injury Scale predot codes. Admission Glasgow Coma Scale (GCS) score, Injury Severity Score (ISS), In-hospital complications, and treatment outcome were compared between patients with and without traumatic injury of major cerebral venous sinuses.
Results: A total of 76 patients were identified with traumatic injury of major cerebral venous sinuses among 453,775 patients who had been admitted with head and neck trauma. The rate of penetrating injury was higher among patients with traumatic injury of major cerebral venous sinuses (11.8% versus 2.5%, p = 0.0001). The patients with traumatic injury of major cerebral venous sinuses had a significantly higher rate of intracranial hemorrhage in comparison to patients without traumatic injury of major cerebral venous sinuses. The odds of in-hospital mortality remained significantly higher for patients with traumatic injury of major cerebral venous sinuses after adjusting for age, gender, admission GCS score, ISS injury type, and presence of intracranial hemorrhage [odds ratio (OR): 6.929; 95% confidence interval (CI) 1.337-35.96; p < 0.020]. The odds of discharge to nursing home remained higher for patients with traumatic injury of major cerebral venous sinuses after adjusting for potential confounders (OR: 1.8401; 95% CI 1.18-2.85, p < 0.0065).
Conclusion: Although infrequent, traumatic injury of major cerebral venous sinuses in head and neck trauma is associated with higher rates of in-hospital mortality and discharge to a nursing home.
背景:脑大静脉窦外伤性损伤的自然历史和流行病学方面尚不完全清楚。我们确定了创伤性脑大静脉窦损伤的发生率以及对创伤性脑损伤和/或头颈部创伤患者预后的影响。方法:采用国家外伤数据库(NTDB) 2009 - 2010年数据文件,采用ICD-9-CM编码对我院收治的所有颅脑外伤或头颈部外伤患者进行识别。NTDB是最大的创伤数据库之一,包含来自美国900多个创伤中心的数据。在这些患者中存在血栓形成、内膜撕裂或脑大静脉窦剥离(外伤性损伤)是通过使用简略损伤量表预点编码来识别的。比较脑大静脉窦外伤性损伤患者和非外伤性脑大静脉窦患者入院时格拉斯哥昏迷评分(GCS)、损伤严重程度评分(ISS)、住院并发症和治疗结果。结果:453775例颅脑外伤患者中,有76例为脑大静脉窦外伤性损伤。脑大静脉窦外伤患者的穿透性损伤发生率较高(11.8%比2.5%,p = 0.0001)。脑大静脉窦外伤患者颅内出血发生率明显高于脑大静脉窦未外伤患者。在调整了年龄、性别、入院GCS评分、ISS损伤类型和是否存在颅内出血等因素后,脑大静脉窦外伤性损伤患者的住院死亡率仍显著较高[优势比(OR): 6.929;95%置信区间(CI) 1.337 ~ 35.96;P < 0.020]。在调整潜在混杂因素后,脑大静脉窦创伤性损伤患者出院的几率仍然较高(OR: 1.8401;95% CI 1.18-2.85, p < 0.0065)。结论:头颈部外伤中脑大静脉窦的创伤性损伤虽然不常见,但与较高的住院死亡率和出院率有关。
{"title":"Traumatic Injury of Major Cerebral Venous Sinuses Associated with Traumatic Brain Injury or Head and Neck Trauma: Analysis of National Trauma Data Bank.","authors":"Adnan I Qureshi, Sindhu Sahito, Jahanzeb Liaqat, Premkumar Nattanmai Chandrasekaran, Farhan Siddiq","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The natural history and epidemiological aspects of traumatic injury of major cerebral venous sinuses are not fully understood. We determined the prevalence of traumatic injury of major cerebral venous sinuses and impact on the outcome of patients with traumatic brain injury, and/or head and neck trauma.</p><p><strong>Methods: </strong>All the patients who were admitted with traumatic brain injury or head and neck trauma were identified by ICD-9-CM codes from the National Trauma Data Bank (NTDB), using data files from 2009 to 2010. NTDB represents one of the largest trauma databases and contains data from over 900 trauma centers across the United States. Presence of thrombosis, intimal tear, or dissection (traumatic injury) of major cerebral venous sinuses was identified in these patients by using Abbreviated Injury Scale predot codes. Admission Glasgow Coma Scale (GCS) score, Injury Severity Score (ISS), In-hospital complications, and treatment outcome were compared between patients with and without traumatic injury of major cerebral venous sinuses.</p><p><strong>Results: </strong>A total of 76 patients were identified with traumatic injury of major cerebral venous sinuses among 453,775 patients who had been admitted with head and neck trauma. The rate of penetrating injury was higher among patients with traumatic injury of major cerebral venous sinuses (11.8% versus 2.5%, <i>p</i> = 0.0001). The patients with traumatic injury of major cerebral venous sinuses had a significantly higher rate of intracranial hemorrhage in comparison to patients without traumatic injury of major cerebral venous sinuses. The odds of in-hospital mortality remained significantly higher for patients with traumatic injury of major cerebral venous sinuses after adjusting for age, gender, admission GCS score, ISS injury type, and presence of intracranial hemorrhage [odds ratio (OR): 6.929; 95% confidence interval (CI) 1.337-35.96; p < 0.020]. The odds of discharge to nursing home remained higher for patients with traumatic injury of major cerebral venous sinuses after adjusting for potential confounders (OR: 1.8401; 95% CI 1.18-2.85, <i>p</i> < 0.0065).</p><p><strong>Conclusion: </strong>Although infrequent, traumatic injury of major cerebral venous sinuses in head and neck trauma is associated with higher rates of in-hospital mortality and discharge to a nursing home.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"27-33"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998802/pdf/jvin-11-1-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37655151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Upright posture intolerance can be seen in a variety of diseases but the current methodology is not quantifiable and limits the ability to identify response to treatment.
Methods: A standard questionnaire was developed to assess the following aspects of upright posture tolerance: (1) How long can you stand straight without any support? (2) Do you feel any sense of sickness when you sit or lie down after standing? (3) How long do you have to wait before you are comfortable standing again after you have stood straight? (4) How effectively and fast can you get up from sitting or lying position to stand straight? and (5) rate the ability to perform activities on a standard vertical visual analog scale between 100 (can do everything) and 0 (cannot do anything). We tested the ability of the questionnaire in four patients to identify various aspects of upright posture intolerance.
Results: The questionnaire was administered to four patients who reported upright posture intolerance. The patients with either intracranial hypotension syndrome, postural hypotension, or Klippel-Feil syndrome reported less than optimal performance in four of five components of the questionnaire. The patient with vertebrobasilar ischemia reported less than optimal performance in two of five components.
Conclusions: A new questionnaire is developed for self-administration to identify various components of upright posture intolerance and detect response to treatment.
{"title":"A New Method for Assessment of Upright Posture Intolerance.","authors":"Adnan I Qureshi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Upright posture intolerance can be seen in a variety of diseases but the current methodology is not quantifiable and limits the ability to identify response to treatment.</p><p><strong>Methods: </strong>A standard questionnaire was developed to assess the following aspects of upright posture tolerance: (1) How long can you stand straight without any support? (2) Do you feel any sense of sickness when you sit or lie down after standing? (3) How long do you have to wait before you are comfortable standing again after you have stood straight? (4) How effectively and fast can you get up from sitting or lying position to stand straight? and (5) rate the ability to perform activities on a standard vertical visual analog scale between 100 (can do everything) and 0 (cannot do anything). We tested the ability of the questionnaire in four patients to identify various aspects of upright posture intolerance.</p><p><strong>Results: </strong>The questionnaire was administered to four patients who reported upright posture intolerance. The patients with either intracranial hypotension syndrome, postural hypotension, or Klippel-Feil syndrome reported less than optimal performance in four of five components of the questionnaire. The patient with vertebrobasilar ischemia reported less than optimal performance in two of five components.</p><p><strong>Conclusions: </strong>A new questionnaire is developed for self-administration to identify various components of upright posture intolerance and detect response to treatment.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"42-45"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998804/pdf/jvin-11-1-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37655154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Claudio E Scherle Matamoros, Edgar A Samaniego, Kimberly Sam, Jorge A Roa, Jesús Pérez Nellar, Danny Rivero Rodríguez
Background: Symptomatic vasospasm (sVSP) is a common complication during the course of aneurysmal subarachnoid hemorrhage (aSAH). We aimed to evaluate the efficacy and accuracy of transcranial Doppler ultrasound (TCD), performed within the first 3 days of aSAH to predict the development of sVSP.
Methods: We performed a retrospective analysis of our institutional prospectively collected database of patients with aSAH. Patients with aSAH and World Federation of Neurosurgical Societies (WFNS) grades I-III were included in the analysis. A receiver operating characteristic (ROC) curve was generated to determine cut-off values for mean flow velocities (MFVs) in the middle cerebral artery (MCA) and anterior cerebral artery (ACA) bilaterally to predict sVSP.
Results: Fifty-one patients were included in the study. Mean age was 49.8 ± 10.2 years, and 84.3% (43 patients) were women. The accuracy of measured MFVs to predict sVSP was 0.79 [95% confidence interval (CI), 0.69-0.89] and 0.77 (95% CI, 0.64-0.91) for the MCA and the ACA, respectively. In the MCA, an MFV ≥ 74 cm/s was significantly associated with a six-fold increased risk of sVSP, achieving sensitivity greater than 70%. In the ACA, an MFV ≥ 64 cm/s was significantly associated with a nine-fold increased risk of sVSP.
Conclusion: Early TCD evaluation of MFVs in the MCA and ACA is a useful tool to predict the development of sVSP in patients with acute aSAH.
{"title":"Prediction of Symptomatic Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage Using Early Transcranial Doppler.","authors":"Claudio E Scherle Matamoros, Edgar A Samaniego, Kimberly Sam, Jorge A Roa, Jesús Pérez Nellar, Danny Rivero Rodríguez","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Symptomatic vasospasm (sVSP) is a common complication during the course of aneurysmal subarachnoid hemorrhage (aSAH). We aimed to evaluate the efficacy and accuracy of transcranial Doppler ultrasound (TCD), performed within the first 3 days of aSAH to predict the development of sVSP.</p><p><strong>Methods: </strong>We performed a retrospective analysis of our institutional prospectively collected database of patients with aSAH. Patients with aSAH and World Federation of Neurosurgical Societies (WFNS) grades I-III were included in the analysis. A receiver operating characteristic (ROC) curve was generated to determine cut-off values for mean flow velocities (MFVs) in the middle cerebral artery (MCA) and anterior cerebral artery (ACA) bilaterally to predict sVSP.</p><p><strong>Results: </strong>Fifty-one patients were included in the study. Mean age was 49.8 ± 10.2 years, and 84.3% (43 patients) were women. The accuracy of measured MFVs to predict sVSP was 0.79 [95% confidence interval (CI), 0.69-0.89] and 0.77 (95% CI, 0.64-0.91) for the MCA and the ACA, respectively. In the MCA, an MFV ≥ 74 cm/s was significantly associated with a six-fold increased risk of sVSP, achieving sensitivity greater than 70%. In the ACA, an MFV ≥ 64 cm/s was significantly associated with a nine-fold increased risk of sVSP.</p><p><strong>Conclusion: </strong>Early TCD evaluation of MFVs in the MCA and ACA is a useful tool to predict the development of sVSP in patients with acute aSAH.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"19-26"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998809/pdf/jvin-11-1-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37655150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We describe a variant where the A2 segment of one anterior cerebral artery anastomose distal to the origin of the anterior communicating artery with the A2 segment of the contralateral anterior cerebral artery. The anastomoses are seen without any hypoplasia or aplasia of A2 segments prior to anastomoses unlike azygous or bihemispheric anterior cerebral artery. The anastomoses occur prior to bifurcation of the anterior cerebral artery into pericallosal and callosomarginal arteries.
{"title":"Post Anterior Communicating Artery Anastomosis.","authors":"Adnan I Qureshi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We describe a variant where the A2 segment of one anterior cerebral artery anastomose distal to the origin of the anterior communicating artery with the A2 segment of the contralateral anterior cerebral artery. The anastomoses are seen without any hypoplasia or aplasia of A2 segments prior to anastomoses unlike azygous or bihemispheric anterior cerebral artery. The anastomoses occur prior to bifurcation of the anterior cerebral artery into pericallosal and callosomarginal arteries.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"40-41"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998805/pdf/jvin-11-1-7.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37655153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ashish Kulhari, Ming He, Farah Fourcand, Amrinder Singh, Haralabos Zacharatos, Siddhart Mehta, Jawad F Kirmani
Background: Idiopathic intracranial hypertension (IIH) is a syndrome of elevated intracranial pressure of unknown etiology. Unilateral or bilateral transverse sinus (TS) or transverse-sigmoid junction stenosis is present in about 30%-93% of these patients. There is an ongoing debate on whether venous sinus stenosis is the cause of IIH or a result of it. The subset of IIH patients who continue to have clinical deterioration despite maximum medical therapy is termed as "refractory IIH." Traditionally, cerebrospinal fluid diversion surgeries (ventriculoperitoneal shunt and lumboperitoneal shunt) and optic nerve sheath fenestration (ONSF) were the mainstays of treatment for refractory IIH. In the last decade, venous sinus stenting (VSS) has emerged as a safe and effective option for treating refractory IIH patients with venous sinus stenosis. Through this study, we want to share our experience with venous stenting in refractory IIH patients with venous sinus stenosis associated with a significant pressure gradient (≥10 mm Hg).
Methods: Retrospective chart review of all the patients diagnosed with refractory IIH who underwent VSS or angioplasty at our comprehensive stroke center from November 2016 to March 2019.
Results: A total of seven refractory IIH patients underwent VSS or angioplasty within the specified period. The mean age was 39 years. Eighty-five percent of the patients were women (n = 6). The mean body mass index (BMI) was 37 kg/m2. Headache was the most common symptom (85%, n = 6) followed by transient visual obscurations (71%, n = 5) and pulsatile tinnitus (57%; n = 4). All patients had papilledema. Fifty-seven percent of patients (n = 4) had impaired visual field. Mean lumbar opening pressure was 40.6 cm H2O (SD = 9.66; 95% CI = 33.5-47.7). All patients were on maximum doses of acetazolamide ± furosemide. Six patients (85%) had dominant right transverse-sigmoid sinus. Fifty-seven percent of the patients had severe right transverse ± sigmoid sinus stenosis (n = 4) and the rest (43%) had bilateral TS stenosis (n = 3). Prestenting mean trans-stenosis pressure gradient was 18 mm Hg (SD = 6.16; 95% CI = 13.43-22.57). Six patients (85%) were treated with TS stenting and one (15%) with only angioplasty. Poststenting mean trans-stenosis pressure gradient was 4.8 mm Hg (SD = 6.6; 95% CI = -0.1-9.7). All patients were able to come off their medications with significant improvement in neurological and ophthalmological signs and symptoms. No procedure-related complications occurred.
Conclusion: TS stenting ± angioplasty is a safe and effective means of treating refractory IIH with venous sinus stenosis associated with a significant pressure gradient (≥10 mm Hg).
背景:特发性颅内高压(IIH)是一种病因不明的颅内压升高综合征。约30%-93%的患者存在单侧或双侧横窦(TS)或横乙状结肠交界处狭窄。关于静脉窦狭窄是IIH的原因还是结果一直存在争议。尽管进行了最大限度的药物治疗,但仍有临床恶化的IIH患者被称为“难治性IIH”。传统上,脑脊液分流手术(脑室-腹膜分流术和腰腹膜分流术)和视神经鞘开窗(ONSF)是治疗难治性IIH的主要方法。在过去的十年中,静脉窦支架置入术(VSS)已成为治疗难治性IIH患者静脉窦狭窄的一种安全有效的选择。通过这项研究,我们希望分享我们在静脉窦狭窄伴明显压力梯度(≥10 mm Hg)的难治性IIH患者中静脉支架置入术的经验。方法:回顾性分析2016年11月至2019年3月在我院卒中综合中心接受VSS或血管成形术治疗的所有难治性IIH患者。结果:共有7例难治性IIH患者在规定时间内接受了VSS或血管成形术。平均年龄39岁。85%的患者为女性(n = 6),平均体重指数(BMI)为37 kg/m2。头痛是最常见的症状(85%,n = 6),其次是短暂性视力模糊(71%,n = 5)和脉动性耳鸣(57%;n = 4)。所有患者均有乳头水肿。57%的患者(n = 4)视野受损。平均腰椎开口压力为40.6 cm H2O (SD = 9.66;95% ci = 33.5-47.7)。所有患者均给予最大剂量乙酰唑胺±呋塞米。6例(85%)以右侧横乙状结肠窦为主。57%的患者有严重的右横±乙状窦狭窄(n = 4),其余43%的患者有双侧TS狭窄(n = 3)。平均跨狭窄压力梯度为18 mm Hg (SD = 6.16;95% ci = 13.43-22.57)。6名患者(85%)接受TS支架治疗,1名患者(15%)仅接受血管成形术治疗。支架术后平均跨狭窄压力梯度为4.8 mm Hg (SD = 6.6;95% ci = -0.1-9.7)。所有患者都能够停止他们的药物治疗,神经和眼科的体征和症状都有显著改善。无手术相关并发症发生。结论:TS支架+血管成形术是治疗难治性IIH伴静脉窦狭窄伴明显压力梯度(≥10 mm Hg)的安全有效的方法。
{"title":"Safety and Clinical Outcomes after Transverse Venous Sinus Stenting for Treatment of Refractory Idiopathic Intracranial Hypertension: Single Center Experience.","authors":"Ashish Kulhari, Ming He, Farah Fourcand, Amrinder Singh, Haralabos Zacharatos, Siddhart Mehta, Jawad F Kirmani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Idiopathic intracranial hypertension (IIH) is a syndrome of elevated intracranial pressure of unknown etiology. Unilateral or bilateral transverse sinus (TS) or transverse-sigmoid junction stenosis is present in about 30%-93% of these patients. There is an ongoing debate on whether venous sinus stenosis is the cause of IIH or a result of it. The subset of IIH patients who continue to have clinical deterioration despite maximum medical therapy is termed as \"refractory IIH.\" Traditionally, cerebrospinal fluid diversion surgeries (ventriculoperitoneal shunt and lumboperitoneal shunt) and optic nerve sheath fenestration (ONSF) were the mainstays of treatment for refractory IIH. In the last decade, venous sinus stenting (VSS) has emerged as a safe and effective option for treating refractory IIH patients with venous sinus stenosis. Through this study, we want to share our experience with venous stenting in refractory IIH patients with venous sinus stenosis associated with a significant pressure gradient (≥10 mm Hg).</p><p><strong>Methods: </strong>Retrospective chart review of all the patients diagnosed with refractory IIH who underwent VSS or angioplasty at our comprehensive stroke center from November 2016 to March 2019.</p><p><strong>Results: </strong>A total of seven refractory IIH patients underwent VSS or angioplasty within the specified period. The mean age was 39 years. Eighty-five percent of the patients were women (<i>n</i> = 6). The mean body mass index (BMI) was 37 kg/m<sup>2</sup>. Headache was the most common symptom (85%, <i>n</i> = 6) followed by transient visual obscurations (71%, <i>n</i> = 5) and pulsatile tinnitus (57%; <i>n</i> = 4). All patients had papilledema. Fifty-seven percent of patients (<i>n</i> = 4) had impaired visual field. Mean lumbar opening pressure was 40.6 cm H<sub>2</sub>O (SD = 9.66; 95% CI = 33.5-47.7). All patients were on maximum doses of acetazolamide ± furosemide. Six patients (85%) had dominant right transverse-sigmoid sinus. Fifty-seven percent of the patients had severe right transverse ± sigmoid sinus stenosis (<i>n</i> = 4) and the rest (43%) had bilateral TS stenosis (<i>n</i> = 3). Prestenting mean trans-stenosis pressure gradient was 18 mm Hg (SD = 6.16; 95% CI = 13.43-22.57). Six patients (85%) were treated with TS stenting and one (15%) with only angioplasty. Poststenting mean trans-stenosis pressure gradient was 4.8 mm Hg (SD = 6.6; 95% CI = -0.1-9.7). All patients were able to come off their medications with significant improvement in neurological and ophthalmological signs and symptoms. No procedure-related complications occurred.</p><p><strong>Conclusion: </strong>TS stenting ± angioplasty is a safe and effective means of treating refractory IIH with venous sinus stenosis associated with a significant pressure gradient (≥10 mm Hg).</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"6-12"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998806/pdf/jvin-11-1-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37654745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tessa A Harland, Joshua Seinfeld, Andrew C White, David A Kumpe, Christopher D Roark, David E Case
Objective: The second-generation pipeline embolization device (PED), flex, has improved opening and resheathing ability compared to the first-generation classic PED device. A previously reported single-institutional study suggests that the PED flex devices are associated with lower rates of complications. However, there was limited discussion regarding the complication rate with respect to microcatheter choice for PED delivery and deployment. The present study aims to evaluate outcomes of aneurysm treatment with PED flex versus classic along with the Phenom microcatheter versus Marksman microcatheter.
Methods: A retrospective, IRB-approved database of all patients who received a PED classic or PED flex device between January 2012 and July 2018 was analyzed. Microcatheter choice, patient demographics, medical comorbidities, aneurysm characteristics, treatment information, and outcome data were analyzed using univariate analyses.
Results: A total of 75 PED procedures were analyzed. There was no significant difference in major complications between the PED classic and PED flex. However, those treated using the Marksman microcatheter were more likely to have a major complication (periprocedural hemorrhage or ischemic event; 16.6% vs. 0%, p = 0.0248) than those treated with the Phenom microcatheter. Within the PED flex cohort, all major complications were associated with the Marksman microcatheter (p = 0.0289).
Conclusions: The present study does not replicate significantly fewer complications with PED flex but demonstrates a significant reduction in complications with the Phenom microcatheter. Ultimately, this suggests multiple factors are involved in achieving positive outcomes and low complication rates in PED treated unruptured cerebral aneurysms.
目的:与第一代经典管道栓塞装置相比,第二代管道栓塞装置(PED)具有更好的打开和重新插管能力。先前报道的一项单一机构研究表明,PED柔性装置与并发症发生率较低有关。然而,关于微导管选择用于PED输送和部署的并发症发生率的讨论有限。本研究旨在评估PED flex与经典、Phenom微导管与Marksman微导管治疗动脉瘤的效果。方法:回顾性分析2012年1月至2018年7月期间接受PED经典或PED柔性装置的所有患者的irb批准数据库。采用单变量分析对微导管选择、患者人口统计学、医疗合并症、动脉瘤特征、治疗信息和结局数据进行分析。结果:共分析了75例PED手术。PED经典和PED屈曲在主要并发症方面无显著差异。然而,使用Marksman微导管治疗的患者更有可能出现主要并发症(术中出血或缺血性事件;16.6% vs. 0%, p = 0.0248)。在PED flex队列中,所有主要并发症均与Marksman微导管相关(p = 0.0289)。结论:目前的研究并没有重复PED flex的并发症显著减少,但显示了Phenom微导管的并发症显著减少。最终,这表明多种因素参与了PED治疗未破裂脑动脉瘤的积极结果和低并发症发生率。
{"title":"Comparative Analysis of Unruptured Cerebral Aneurysm Treatment Outcomes and Complications with the Classic versus Flex Pipeline Embolization Devices and Phenom versus Marksman Microcatheter Delivery System: The Role of Microcatheter Choice on Complication Rate.","authors":"Tessa A Harland, Joshua Seinfeld, Andrew C White, David A Kumpe, Christopher D Roark, David E Case","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>The second-generation pipeline embolization device (PED), flex, has improved opening and resheathing ability compared to the first-generation classic PED device. A previously reported single-institutional study suggests that the PED flex devices are associated with lower rates of complications. However, there was limited discussion regarding the complication rate with respect to microcatheter choice for PED delivery and deployment. The present study aims to evaluate outcomes of aneurysm treatment with PED flex versus classic along with the Phenom microcatheter versus Marksman microcatheter.</p><p><strong>Methods: </strong>A retrospective, IRB-approved database of all patients who received a PED classic or PED flex device between January 2012 and July 2018 was analyzed. Microcatheter choice, patient demographics, medical comorbidities, aneurysm characteristics, treatment information, and outcome data were analyzed using univariate analyses.</p><p><strong>Results: </strong>A total of 75 PED procedures were analyzed. There was no significant difference in major complications between the PED classic and PED flex. However, those treated using the Marksman microcatheter were more likely to have a major complication (periprocedural hemorrhage or ischemic event; 16.6% vs. 0%, <i>p</i> = 0.0248) than those treated with the Phenom microcatheter. Within the PED flex cohort, all major complications were associated with the Marksman microcatheter (<i>p</i> = 0.0289).</p><p><strong>Conclusions: </strong>The present study does not replicate significantly fewer complications with PED flex but demonstrates a significant reduction in complications with the Phenom microcatheter. Ultimately, this suggests multiple factors are involved in achieving positive outcomes and low complication rates in PED treated unruptured cerebral aneurysms.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"11 1","pages":"13-18"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998803/pdf/jvin-11-1-3.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37654746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wled Wazni, Salman Farooq, John-Andrew Cox, Christopher Southwood, Gregory Rozansky, Thomas V Kodankandath, Vijay Johnson, John R Lynch
Delayed cerebral ischemia (DCI) due to cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH) has long been recognized as a major source of morbidity and mortality. Early detection of cerebral vasospasm and identification of patients who are likely to become symptomatic is crucial to guide aggressive medical and/or endovascular interventions. Magnetic resonance imaging using arterial spin-label (ASL) is a noninvasive mean for assessing cerebral blood flow and is based on direct magnetic labeling of arterial blood water protons. The diagnostic role of ASL in acute ischemic stroke, epilepsy, and neurodegenerative disorders has been explained in multiple studies but its ability to predict vasospasm in aSAH has not been published before. The purpose of this study is to highlight the diagnostic implications of different perfusion patterns of ASL in patients with aSAH which can be utilized to prevent DCI in such patients when other commonly used modalities are not available, contraindicated, or fail to detect vasospasm.
动脉瘤性蛛网膜下腔出血(aSAH)后脑血管痉挛导致的延迟性脑缺血(DCI)一直被认为是发病率和死亡率的主要来源。早期发现脑血管痉挛并识别可能出现症状的患者对于指导积极的药物和/或血管内介入治疗至关重要。使用动脉自旋标记(ASL)的磁共振成像是评估脑血流的一种无创手段,它基于动脉血水质子的直接磁标记。ASL 在急性缺血性脑卒中、癫痫和神经退行性疾病中的诊断作用已在多项研究中得到说明,但其预测急性脑梗死血管痉挛的能力尚未发表。本研究旨在强调 ASL 不同灌注模式对 aSAH 患者的诊断意义,当其他常用模式无法使用、有禁忌症或无法检测到血管痉挛时,可利用 ASL 预防此类患者的 DCI。
{"title":"Use of Arterial Spin-Labeling in Patients with Aneurysmal Sub-arachnoid hemorrhage.","authors":"Wled Wazni, Salman Farooq, John-Andrew Cox, Christopher Southwood, Gregory Rozansky, Thomas V Kodankandath, Vijay Johnson, John R Lynch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Delayed cerebral ischemia (DCI) due to cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH) has long been recognized as a major source of morbidity and mortality. Early detection of cerebral vasospasm and identification of patients who are likely to become symptomatic is crucial to guide aggressive medical and/or endovascular interventions. Magnetic resonance imaging using arterial spin-label (ASL) is a noninvasive mean for assessing cerebral blood flow and is based on direct magnetic labeling of arterial blood water protons. The diagnostic role of ASL in acute ischemic stroke, epilepsy, and neurodegenerative disorders has been explained in multiple studies but its ability to predict vasospasm in aSAH has not been published before. The purpose of this study is to highlight the diagnostic implications of different perfusion patterns of ASL in patients with aSAH which can be utilized to prevent DCI in such patients when other commonly used modalities are not available, contraindicated, or fail to detect vasospasm.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"10 3","pages":"10-14"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141636088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}